Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia V: Nursing management and Prevention01:30

Pneumonia V: Nursing management and Prevention

4.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
4.1K
Probiotics01:22

Probiotics

272
Probiotics are live, non-pathogenic microorganisms that confer health benefits by modulating the gut microbiota. The human gastrointestinal tract harbors a complex microbial ecosystem, and the balance of this microbiota is crucial for digestive and systemic health. Among the most extensively studied and utilized probiotics are species formerly classified within the genera Lactobacillus and Bifidobacterium. These organisms not only naturally colonize the human gut but are also consumed through...
272
Pneumonia IV: Management01:28

Pneumonia IV: Management

1.1K
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
1.1K
Microbiota of the Respiratory Tract01:29

Microbiota of the Respiratory Tract

52
The human respiratory tract, comprising the upper and lower segments, serves as a critical interface with the external environment. The upper respiratory tract (URT)—including the nostrils, sinuses, pharynx, and oropharynx—is heavily colonized by microbes, while the lower respiratory tract (LRT), composed of the larynx, trachea, bronchi, and lungs, was long thought to be sterile. However, recent molecular studies have revealed that the lungs are not devoid of microbes but act more...
52
Healthcare Associated Infections II: Preventive Measures01:22

Healthcare Associated Infections II: Preventive Measures

4.7K
Essential infection prevention measures are based on the knowledge of the infection chain, the modes of transmission in healthcare settings, and the use of the best practices in all healthcare settings. Compulsory public reporting of healthcare-associated infection rates is needed to allow individuals and the community to make informed choices regarding selecting a healthcare facility.
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...
4.7K
Transmission-based Precautions II: Airborne and Protective Environment01:25

Transmission-based Precautions II: Airborne and Protective Environment

2.0K
Transmission-based precautions are for patients infected or suspected to be infected (or colonized) with organisms posing a significant risk to others. The transmission precautions include airborne and protective environment precautions.
Airborne precautions:
Use airborne precautions when treating patients known or suspected to have diseases that spread through the air—for example, tuberculosis or measles. These organisms are present in smaller droplets expelled by an infected person and...
2.0K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The challenges of self-management among patients with recurrent hypertriglyceridemic acute pancreatitis: a qualitative study.

Scientific reports·2026
Same author

Reappraising the fascia iliaca compartment block and pericapsular nerve group block for geriatric hip fractures: a narrative review.

Journal of anesthesia, analgesia and critical care·2026
Same author

Beyond the Binary: Integrating Novel G Protein-Biased Opioids Into the Opioid-Free Anesthesia Debate.

Anesthesia and analgesia·2026
Same author

Intravenous dextrose for post-gastrointestinal endoscopy dizziness.

Gastrointestinal endoscopy·2026
Same author

Targeting VISTA for immunomodulation in sepsis: mechanisms and therapeutic potentials.

Frontiers in immunology·2026
Same author

The dual balance of the cytokine network: key messengers of immune activation and triggers of cytokine storm.

Biomarker research·2026

Related Experiment Video

Updated: Apr 21, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

11.9K

Probiotics for preventing ventilator-associated pneumonia.

Lulong Bo1, Jinbao Li, Tianzhu Tao

  • 1Department of Anaesthesiology and Intensive Care Medicine, Changhai Hospital, Second Military Medical University, 14th Floor, 168 Changhai Rd, Shanghai, China, 200433.

The Cochrane Database of Systematic Reviews
|October 26, 2014
PubMed
Summary

Probiotics may reduce ventilator-associated pneumonia (VAP) incidence in intensive care units (ICUs), but evidence quality is low. Further research is needed to confirm efficacy and safety for VAP prevention.

More Related Videos

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.2K
Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

21.0K

Related Experiment Videos

Last Updated: Apr 21, 2026

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
09:20

Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay

Published on: April 28, 2014

11.9K
Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia
04:32

Murine Oropharyngeal Aspiration Model of Ventilator-associated and Hospital-acquired Bacterial Pneumonia

Published on: June 28, 2018

11.2K
Probiotic Studies in Neonatal Mice Using Gavage
10:36

Probiotic Studies in Neonatal Mice Using Gavage

Published on: January 27, 2019

21.0K

Area of Science:

  • Critical Care Medicine
  • Infectious Diseases
  • Microbiology

Background:

  • Ventilator-associated pneumonia (VAP) is a frequent complication in intensive care units (ICUs).
  • Emerging evidence suggests probiotics may offer a protective effect against VAP development.
  • Existing studies indicate probiotics are generally safe and potentially effective for VAP prevention.

Purpose of the Study:

  • To systematically review and synthesize data from randomized controlled trials (RCTs) on probiotics for VAP prevention.
  • To evaluate the overall effectiveness and safety profile of probiotic interventions in ICU patients at risk for VAP.

Main Methods:

  • Searched major databases (CENTRAL, MEDLINE, EMBASE) for relevant RCTs published up to September 2014.
  • Included RCTs comparing probiotics with placebo or other controls for VAP prevention.
  • Two independent reviewers assessed study eligibility, quality, and extracted data.

Main Results:

  • Eight RCTs involving 1083 participants were included.
  • Probiotic use showed a trend towards reduced VAP incidence (OR 0.70, 95% CI 0.52-0.95) with low-quality evidence.
  • Uncertainty remains regarding effects on mortality, diarrhea, ICU stay, ventilation duration, and antibiotic use due to very low to low-quality evidence and wide confidence intervals.

Conclusions:

  • Probiotics may be associated with a reduced incidence of VAP, but the evidence quality is low.
  • The current evidence is insufficient to establish the efficacy and safety of probiotics for preventing VAP in ICU patients.
  • Further high-quality research is warranted to clarify the role of probiotics in VAP prevention strategies.